Long-term outcome of individuals with pure red cell aplasia and antierythropoietin antibodies in patients treated with recombinant epoetin: A follow-up report from the Research on Adverse Drug Events and Reports (RADAR) Project.
Times cited: 65
Pure red-cell aplasia and epoetin therapy.
New England Journal of Medicine.
Times cited: 322